Back to search

Article

All-trans retinoic acid (ATRA) reduces proliferative capacity and Brachyury levels in chordoma cells

2020-01-09

Abstract excerpt

Chordoma is a rare bone cancer for which there are no approved drugs. Surgery is the principle treatment but complete resection can be challenging due to the location of the tumours in the spine and therefore finding an effective drug treatment is a pressing unmet clinical need. A major recent study identified the transcription factor Brachyury as the primary vulnerability and drug target in chordoma. Previously,...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
45f75eee-f078-5b7b-b08d-b604b61f6a1a
DOI
10.1101/2020.01.09.897314
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
All-trans retinoic acid (ATRA) reduces proliferative capacity and Brachyury levels in chordoma cellsDOI 10.1101/2020.01.09.897314
Select a neighboring publication to make it the new centre.